NEW INSIGHT: IN-SILICO ANALYSIS OF PHYTOCHEMICALS AS A THERAPEUTIC INTERVENTION AGAINST MENINGIOMA

Abstract

Drug development for conventional delivery targets is the major challenge for therapeutic progress. PI3K signaling has shown a prominent role in progression of meningioma which subsequently makes these receptors a target for efficient treatment approach. Loss or alteration of NF2 (neurofibromin 2) with respect to its gene product merlin is crucially implicated in tumor development eventually leads to the meningioma. However, the interactions of meningioma pathophysiology (merlin) to many pathways makes it complicated. Different signalling pathways interacting with merlin are the hippo pathway, PI3K /Akt route and mTORC pathway. We thesis on the inhibitory approach for P13K pathway and phosphorylation of Akt to terminate merlin polyubiquitination and promote its expression and association with PIKE-L thereby activating tumor suppressive action. Our work emphasizes on exploring biological compounds that target the PI3K pathway using the in-silico method. Here, we implemented 50 phytochemicals from various plant sources against PI3K for molecular docking and assessed as a potential anticancer drug. The docking was performed showing binding energy, drug likeness and affinity of different phytochemicals. The following study demonstrated various phytochemicals (such as Leachianone A, withaferin A, kurarinol and gardenoilic acid B) along with comparing their ADME score, bioavailability radar and score that provides insights on possible therapeutic approach of these biological compounds.